Cargando…

Iron and Targeted Iron Therapy in Alzheimer’s Disease

Alzheimer’s disease (AD) is the most common neurodegenerative disease worldwide. β-amyloid plaque (Aβ) deposition and hyperphosphorylated tau, as well as dysregulated energy metabolism in the brain, are key factors in the progression of AD. Many studies have observed abnormal iron accumulation in di...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Jian, Fu, Jiaying, Zhao, Yuanxin, Liu, Qingqing, Yan, Xiaoyu, Su, Jing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10671546/ https://www.ncbi.nlm.nih.gov/pubmed/38003544 http://dx.doi.org/10.3390/ijms242216353

Ejemplares similares

Aβ and Tau Regulate Microglia Metabolism via Exosomes in Alzheimer’s Disease
por: Zhao, Yuanxin, et al.
Publicado: (2022)

The Influence of Mitochondrial-DNA-Driven Inflammation Pathways on Macrophage Polarization: A New Perspective for Targeted Immunometabolic Therapy in Cerebral Ischemia-Reperfusion Injury
por: Yu, Sihang, et al.
Publicado: (2021)

The Roles of Histone Deacetylases in the Regulation of Ovarian Cancer Metastasis
por: Xu, Long, et al.
Publicado: (2023)

Tumor Cells Transmit Drug Resistance via Cisplatin-Induced Extracellular Vesicles
por: Wang, Jian, et al.
Publicado: (2023)

H-TEX-mediated signaling between hepatocellular carcinoma cells and macrophages and exosome-targeted therapy for hepatocellular carcinoma
por: Yu, Sihang, et al.
Publicado: (2022)

Iron Homeostasis Disorder and Alzheimer’s Disease
por: Peng, Yu, et al.
Publicado: (2021)

ROS-Induced mtDNA Release: The Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression
por: Zhao, Yuanxin, et al.
Publicado: (2021)

Iron Metabolism, Ferroptosis, and the Links With Alzheimer’s Disease
por: Yan, Nao, et al.
Publicado: (2020)

Correlative Microscopy to Localize and Characterize Iron Deposition in Alzheimer’s Disease
por: Madsen, Steven J., et al.
Publicado: (2020)

Cellular Senescence and Iron Dyshomeostasis in Alzheimer’s Disease
por: Masaldan, Shashank, et al.
Publicado: (2019)

Iron Dysregulation in Mitochondrial Dysfunction and Alzheimer’s Disease
por: Onukwufor, John O., et al.
Publicado: (2022)

Macrophage Polarization Mediated by Mitochondrial Dysfunction Induces Adipose Tissue Inflammation in Obesity
por: Xu, Long, et al.
Publicado: (2022)

Iron in Alzheimer’s Disease: From Physiology to Disease Disabilities
por: Pal, Amit, et al.
Publicado: (2022)

Targeting iron metabolism in cancer therapy
por: Morales, Michael, et al.
Publicado: (2021)

Nanomedicine targets iron metabolism for cancer therapy
por: Lin, Liangru, et al.
Publicado: (2022)

Targeting iron metabolism in osteosarcoma
por: Ma, Xiaowei, et al.
Publicado: (2023)

Copper, Iron, Selenium and Lipo-Glycemic Dysmetabolism in Alzheimer’s Disease
por: Aaseth, Jan, et al.
Publicado: (2021)

Iron Therapy in Inflammatory Bowel Disease
por: Kumar, Aditi, et al.
Publicado: (2020)

Iron and oxidizing species in oxidative stress and Alzheimer's disease
por: Zhao, Zhongwei
Publicado: (2019)

Iron Therapy in Patients with Heart Failure and Iron Deficiency: Review of Iron Preparations for Practitioners
por: Drozd, Marcin, et al.
Publicado: (2016)

Iron and Alzheimer’s Disease: From Pathogenesis to Therapeutic Implications
por: Liu, Jun-Lin, et al.
Publicado: (2018)

Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy
por: Peng, Xiang-Hong, et al.
Publicado: (2008)

Ceruloplasmin and iron in Alzheimer’s disease and Parkinson’s disease: a synopsis of recent studies
por: Kristinsson, Jakob, et al.
Publicado: (2012)

Investigation of brain iron levels in Chinese patients with Alzheimer’s disease
por: Huang, Chuanbin, et al.
Publicado: (2023)

Cortical Iron Reflects Severity of Alzheimer’s Disease
por: van Duijn, Sara, et al.
Publicado: (2017)

Iron and Alzheimer’s Disease: From Pathology to Imaging
por: Tran, Dean, et al.
Publicado: (2022)

Anemia and Iron Deficiency in Cancer Patients: Role of Iron Replacement Therapy
por: Busti, Fabiana, et al.
Publicado: (2018)

HDAC9 Contributes to Serous Ovarian Cancer Progression through Regulating Epithelial–Mesenchymal Transition
por: Xu, Long, et al.
Publicado: (2022)

The Neuroprotective Activities of the Novel Multi-Target Iron-Chelators in Models of Alzheimer’s Disease, Amyotrophic Lateral Sclerosis and Aging
por: Kupershmidt, Lana, et al.
Publicado: (2023)

Dysregulation of Iron Metabolism in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis
por: Oshiro, Satoru, et al.
Publicado: (2011)

Iron as a therapeutic target in chronic liver disease
por: Kouroumalis, Elias, et al.
Publicado: (2023)

Iron Deficiency as a Therapeutic Target in Cardiovascular Disease
por: Lakhal-Littleton, Samira
Publicado: (2019)

The Role of Iron and Iron Overload in Chronic Liver Disease
por: Milic, Sandra, et al.
Publicado: (2016)

Iron therapy for the treatment of iron deficiency in chronic heart failure: intravenous or oral?
por: McDonagh, Theresa, et al.
Publicado: (2015)

Iron Metabolism in Cancer
por: Wang, Yafang, et al.
Publicado: (2018)

Ceruloplasmin and Iron Proteins in the Serum of Patients with Alzheimer's Disease
por: Torsdottir, Gudlaug, et al.
Publicado: (2011)

A potential pathogenetic role of iron in Alzheimer's disease
por: Silvestri, Laura, et al.
Publicado: (2008)

Therapeutic Potential of Iron Chelating Therapy: Modification of Disease by Iron Depletion
por: Hershko, Chaim, et al.
Publicado: (1994)

Iron Dyshomeostasis and Ferroptosis: A New Alzheimer’s Disease Hypothesis?
por: Wang, Feixue, et al.
Publicado: (2022)

Iron-Refractory Iron Deficiency Anemia
por: Yılmaz Keskin, Ebru, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_u0m4u1qigokgkp5ug0o8aai30e